FSMAX
Price
$77.15
Change
+$1.14 (+1.50%)
Updated
Apr 11 closing price
Net Assets
36.55B
TCGCX
Price
$17.99
Change
+$0.24 (+1.35%)
Updated
Apr 11 closing price
Net Assets
190.61M
Ad is loading...

FSMAX vs TCGCX

Header iconFSMAX vs TCGCX Comparison
Open Charts FSMAX vs TCGCXBanner chart's image
Fidelity Extended Market Index
Price$77.15
Change+$1.14 (+1.50%)
VolumeN/A
Net Assets36.55B
Thornburg Small/Mid Cap Growth C
Price$17.99
Change+$0.24 (+1.35%)
VolumeN/A
Net Assets190.61M
FSMAX vs TCGCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSMAX vs. TCGCX commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Buy and TCGCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 36.5B vs. TCGCX (191M). FSMAX pays higher dividends than TCGCX: FSMAX (0.53) vs TCGCX (0.00). FSMAX was incepted earlier than TCGCX: FSMAX (14 years) vs TCGCX (24 years). TCGCX (3.12) is less costly to investors than FSMAX (0.04). TCGCX is a more actively managed with annual turnover of: 57.56 vs. FSMAX (9.00). FSMAX has a lower initial minimum investment than TCGCX: FSMAX (0) vs TCGCX (5000). FSMAX annual gain was more profitable for investors over the last year : -5.89 vs. TCGCX (-14.05). FSMAX return over 5 years is better than : 59.91 vs. TCGCX (-40.03).
FSMAXTCGCXFSMAX / TCGCX
Total Expense Ratio0.042.341%
Annual Report Gross Expense Ratio0.043.121%
Fund Existence14 years24 years-
Gain YTD-16.362-19.03786%
Front LoadN/AN/A-
Min. Initial Investment05000-
Min. Initial Investment IRAN/AN/A-
Net Assets36.5B191M19,110%
Annual Yield % from dividends0.530.00-
Returns for 1 year-5.89-14.0542%
Returns for 3 years3.94-7.79-51%
Returns for 5 years59.91-40.03-150%
Returns for 10 years42.51-30.22-141%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSHA1.250.08
+6.41%
Taysha Gene Therapies
SIDU1.380.08
+6.15%
Sidus Space
XYL109.061.38
+1.28%
Xylem
GB7.380.03
+0.41%
Global Blue Group Holding AG
UMBF86.40-1.74
-1.97%
UMB Financial Corp